Product Information
- Morpholine, 4-[(2R)-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-[(1S)-1-methylpropyl]-2,5-dioxo-1-piperazinyl](2,6-dimethyl-3-pyridinyl)acetyl]-
- (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
- GSK 557296
- 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-
Epelsiban is a drug that belongs to the class of oxime derivatives. It is used as a modulator and has been shown to have specific treatment effects in animal studies. Epelsiban is also an enantioselective method which targets the oxytocin receptor and has been shown to have single-dose pharmacokinetics. Epelsiban has been shown to be safe in animals, although it can cause adverse reactions such as drug reactions, nausea, vomiting and diarrhea. Epelsiban may also cause endometrial hyperplasia and uterine cancer in women.
Chemical properties
Technical inquiry about: 3D-XJB59983 Epelsiban
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
